---
title: "Cancer Cell：类器官之父最新论文，为肺部神经内分泌肿瘤带来治疗新靶点"
date: 2023-12-12T04:07:24Z
draft: ["false"]
tags: [
  "fetched",
  "生物世界"
]
categories: ["Acdemic"]
---
Cancer Cell：类器官之父最新论文，为肺部神经内分泌肿瘤带来治疗新靶点 by 生物世界
------
<div><p data-mpa-powered-by="yiban.io"><img data-backh="284" data-backw="578" data-croporisrc="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmaC3j3ZL7GqcOpOtTFTrqADHGdLxxkNdwpiaXFvDnxPvTKc2mBrAJaCBEN8CMiaZeaGA6qQTkmLLTQ/0?wx_fmt=jpeg" data-cropx1="0" data-cropx2="1280" data-cropy1="0" data-cropy2="628.9273356401385" data-imgfileid="100224379" data-ratio="0.49074074074074076" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmaC3j3ZL7GqcOpOtTFTrqABFIEb4CjCNnXCR1P7jTWCOia2yFQ0LSzHf0yZcJlJRoMoW9jO2JyM5Q/640?wx_fmt=jpeg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type="jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmaC3j3ZL7GqcOpOtTFTrqABFIEb4CjCNnXCR1P7jTWCOia2yFQ0LSzHf0yZcJlJRoMoW9jO2JyM5Q/640?wx_fmt=jpeg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></p><section><img data-backh="28" data-backw="578" data-cropselx1="0" data-cropselx2="562" data-cropsely1="0" data-cropsely2="28" data-galleryid="" data-imgfileid="100224378" data-ratio="0.049074074074074076" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJnbROJOhnnoLrV6qESwv9dltuvrqKIuTXczPEFP4P0BECicia19nSEewRAibITp6e3Z9C4wHVTCVVOpg/640?wx_fmt=jpeg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type="jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJnbROJOhnnoLrV6qESwv9dltuvrqKIuTXczPEFP4P0BECicia19nSEewRAibITp6e3Z9C4wHVTCVVOpg/640?wx_fmt=jpeg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></section><section><span>撰文丨王聪</span></section><section><span>编辑丨王多鱼</span></section><section><span>排版丨水成文</span></section><section><br></section><section><span><span>2009年，荷兰 Hubrecht 研究所的 </span><span><strong>Hans Clevers</strong></span><span> 等人使用来自小鼠肠道的成体干细胞培育出首个<strong>肠道类器官</strong>，开创了类器官研究的时代。此后，Hans Clevers 成立了类器官技术孵化公司 Hubrecht Organoid Technology ，并成功孵化了多家类器官研究公司。<br></span></span></section><section><br></section><section><span>自2009年以来，类器官领域研究成果不断，许多新型类器官和更复杂的类器官不断涌现，为新药研发、精准治疗、再生医学等领域带来了更强大的工具</span><span>。</span></section><section><br></section><section><strong><span>神经内分泌肿瘤</span></strong><span>（NEN）</span><span>包括高分化的<strong>神经内分泌瘤</strong><span>（NET）</span>和低分化的<strong>神经内分泌癌</strong><span>（NEC）</span>。</span><span>由于缺乏准确的研究模型，NEN患者的治疗选择有限。</span></section><section><br></section><section><span>2023年12月11日，<strong>Hans Clevers</strong> 团队在 <strong>Cancer Cell</strong> 期刊发表了题为：<span>Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites </span>的研究论文。</span></section><section><span><br></span></section><section><span>该研究从肺部<strong>神经内分泌瘤</strong><span>（NET）</span>建立了<strong>患者来源的肿瘤类器官</strong></span><span>（PDTO）</span><span>，并从NEC的一个未被充分研究的亚型——<strong>大细胞神经内分泌癌</strong><span>（LCNEC）</span>中构建了PDTO，这些PDTO保持了来源肿瘤的基因表达模式、瘤内异质性和进化过程。</span></section><section><span><br></span></section><section><span>该研究进一步确定<strong>ASCL1</strong>是LCNEC对BCL-2抑制剂治疗反应的潜在生物标志物。此外，该研究还发现肺部NET患者来源的肿瘤类器官<span>（PDTO）</span>对<strong>EGF</strong>的依赖性。与这些发现一致的是，研究团队在一个独立队列中发现，大约50%的肺部NET表达EGFR。该研究确定了一个可成药的肺部NET亚型的脆弱性，强调了这些患者来源的肿瘤类器官<span>（PDTO）</span>模型的实用性。</span></section><section><br></section><section><span><img data-imgfileid="100224384" data-ratio="0.44166666666666665" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJnwxD5kjKsYNN80EgooHqVkTIsG4UZfu8Ib5fdtzsdpfohlxaXJpLJ7OKR31qnWh0OREquhNapfPw/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJnwxD5kjKsYNN80EgooHqVkTIsG4UZfu8Ib5fdtzsdpfohlxaXJpLJ7OKR31qnWh0OREquhNapfPw/640?wx_fmt=png&amp;from=appmsg"></span></section><section><br></section><section><strong><span>神经内分泌肿瘤</span></strong><span>（NEN）</span><span>具有神经内分泌分化的特征，在肺和胃肠胰系统中发病率最高，包括两种不同的实体：<strong>神经内分泌瘤</strong><span>（NET）</span>和<strong>神经内分泌癌</strong><span>（NEC）</span>，后者是低分化、高级别肿瘤，中位预期寿命不足1年。NEC可进一步细分为<strong>小细胞NEC</strong>和<strong>大细胞NEC</strong>。</span></section><section><br></section><section><span>小细胞NEC最常见于肺部，小细胞肺癌<span>（SCLC）</span>约占所有肺癌的15%，并且比其他NEC研究得更深入。大细胞NEC</span><span><span>（</span><span>LCNEC）</span></span><span>在胃肠胰</span><span>（GEP）</span><span>中更为常见。无论组织部位，治疗LCNEC患者的指南仍然很初级。SCLC的治疗指南是否适用于LCNEC患者，目前尚不清楚。</span></section><section><br></section><section><span>NET是高分化、低级别肿瘤<span>（G1和G2）</span>。虽然低级别NET通常预后良好，但高达35%的NET患者存在转移，导致整体生存率显著下降。转移性G2期肺部NET患者的10年疾病特异性生存率为18%，目前尚不清楚这些患者的最佳治疗策略。</span></section><section><br></section><section><span>对肺部NET的分子分析将其分为三组：侵袭性较小的A1组和A2组，以及侵袭性更大的B组。之前有发现了一个肺部NET亚组，称为<strong>supra-carcinoids</strong>，具有低级别NET的组织病理学特征，但分子特征为<span>大细胞NEC</span><span><span>（</span><span>LCNEC）</span></span>的高侵袭性肿瘤。与G1/G2肺部NET相比，supra-carcinoids的10年总生存率较低，这表明了其临床相关性。</span></section><section><br></section><section><span>其他对肺部NEN的分析已经确定了与supra-carcinoids具有相似特征的肿瘤亚群，并且有几篇已发表的报告显示了高分化肺部NET的高度疾病特征。但目前总体对supra-carcinoids的生物学知之甚少。</span></section><section><br></section><section><span>对于LCNEC或临床上侵袭性NET患者缺乏明确的治疗标准，这突显了临床上未满足的需求。对小细胞肺癌<span>（SCLC）</span>研究受益于其多种疾病模型，然而，<strong><span>大细胞NEC</span></strong><span><span>（</span><span>LCNEC）</span></span>和<strong>神经内分泌瘤</strong><span>（NET）</span>研究因缺乏临床前模型来测试关于<strong><span>神经内分泌肿瘤</span></strong><span>（NEN）</span>潜在治疗靶点和进展机制的假设而受到阻碍。</span></section><section><br></section><section><strong><span>患者来源的肿瘤类器官</span></strong><span>（PDTO）</span><span>是肿瘤细胞的三维培养物，可以长期扩增，并代表其来源肿瘤组织。迄今为止，只有少数PDTO来自高级别<strong><span>神经内分泌肿瘤</span></strong><span>（NEN）</span>，包括SCLC、肺部LCNEC和G3级<span>胃肠胰</span>NET和NEC。</span></section><section><span><br></span></section><section><span>在这项研究中，研究团队建立了<strong><span>神经内分泌肿瘤</span></strong><span>（NEN）</span>患者来源的肿瘤类器官<span>（PDTO）</span>的，包括低级别肺部NET<span>（LNET）</span>和来自多个组织部位的<span>大细胞NEC</span><span><span>（</span><span>LCNEC）</span></span>患者来源的肿瘤类器官<span>（PDTO）</span>，还描述了小肠NET<span>（SINET）</span>患者<span>来源的肿瘤类器官</span><span>（PDTO）</span>的短期培养。</span></section><section><span><br></span></section><section><span><img data-backh="415" data-backw="578" data-imgfileid="100224393" data-ratio="0.718172983479106" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJnwxD5kjKsYNN80EgooHqVkm4nJ5VHSKiauiak6J5GUeKtZYO37H8FPXNeTOTxlmnepg6iaACHiaibKSZQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1029" src="https://mmbiz.qpic.cn/sz_mmbiz_png/HO0Z9pUcnJnwxD5kjKsYNN80EgooHqVkm4nJ5VHSKiauiak6J5GUeKtZYO37H8FPXNeTOTxlmnepg6iaACHiaibKSZQ/640?wx_fmt=png&amp;from=appmsg"></span></section><section><br></section><section><span>通过多组学和表型分析，研究团队证实了<span><strong><span>神经内分泌肿瘤</span></strong><span>（NEN）</span>患者来源的肿瘤类器官<span>（PDTO）</span></span>对其来源肿瘤的忠实度，并表明了它们保留了肿瘤内部的异质性和活跃的进化过程。利用这个平台，该研究发现了肺部NET雅兴中一个潜在的可成药治疗弱点，表明生长因子依赖可能是这些肿瘤的一个特征，可以用于治疗。</span></section><section><br></section><section><span><img data-backh="578" data-backw="547" data-croporisrc="https://mmbiz.qpic.cn/sz_mmbiz_jpg/HO0Z9pUcnJnwxD5kjKsYNN80EgooHqVk0UyuX9Cictc7WicW6O2g3XHhibMDYaqcUTdL4ibDc2f94sbVXMibUWxLk9w/0?wx_fmt=jpeg&amp;from=appmsg" data-cropx1="25.847750865051903" data-cropx2="968.4290657439446" data-cropy1="0" data-cropy2="996" data-imgfileid="100224381" data-ratio="1.056203605514316" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/HO0Z9pUcnJnwxD5kjKsYNN80EgooHqVkUbDu4nfrfeenwdJjOulxiaeZRPloDDYtcibLluCiaFUgEEb2Bb2kWx39Q/640?wx_fmt=jpeg" data-type="jpeg" data-w="943" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/HO0Z9pUcnJnwxD5kjKsYNN80EgooHqVkUbDu4nfrfeenwdJjOulxiaeZRPloDDYtcibLluCiaFUgEEb2Bb2kWx39Q/640?wx_fmt=jpeg"></span></section><section><br></section><section><strong><span>论文链接</span></strong><span>：<br></span></section><p><span>https://doi.org/10.1016/j.ccell.2023.11.007</span></p><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247649820&amp;idx=1&amp;sn=1c6ff4767bbb6040f157864685d8a987&amp;chksm=fbf87ec9cc8ff7dfc75a38ee561a5ab1629ce16bcd398f8f3f6b2803e27e41d8b5b7e8a00d2a&amp;scene=21#wechat_redirect" textvalue="你已选中了添加链接的内容" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="1"><span><span><img data-backh="238" data-backw="562" data-imgfileid="100224399" data-ratio="0.42314814814814816" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJnrjgR9xicl0z6CqtEictIb22ibOib4ZaScu8iaVzglysI6FEiaO8Ibdxmiaq3erkM7zGN5pIiavvhDK3ibic8w/640?wx_fmt=jpeg" data-type="jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJnrjgR9xicl0z6CqtEictIb22ibOib4ZaScu8iaVzglysI6FEiaO8Ibdxmiaq3erkM7zGN5pIiavvhDK3ibic8w/640?wx_fmt=jpeg"></span></span></a></p><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247621729&amp;idx=1&amp;sn=0b1790f407481f969fabd9154243386c&amp;chksm=fbf7e8b4cc8061a223e56c3ffa17e695a0db36f140f7aa33a3183f8d70bb4bb2f7e737ef8e95&amp;scene=21#wechat_redirect" textvalue="你已选中了添加链接的内容" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="1"><span><span><img data-backh="239" data-backw="562" data-cropselx1="0" data-cropselx2="578" data-cropsely1="0" data-cropsely2="246" data-imgfileid="100224401" data-ratio="0.425" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJlWbuKag8C1QqKNCZj4oCWmVxeB88hG8DQLAwnCvGYCLiadGBD0Ve30UVSyeuoxykdujW6CbhyxYzQ/640?wx_fmt=jpeg" data-type="jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJlWbuKag8C1QqKNCZj4oCWmVxeB88hG8DQLAwnCvGYCLiadGBD0Ve30UVSyeuoxykdujW6CbhyxYzQ/640?wx_fmt=jpeg"></span></span></a></p><section data-role="outer" label="Powered by 135editor.com"><section><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><img data-fileid="100088548" data-imgfileid="100224398" data-ratio="0.2573099415204678" data-src="https://mmbiz.qpic.cn/mmbiz_png/73icnXvmN7wOI0rvtgpcAvoymzwXc4GsnicX7nxUa21NoWg2J48JaZ95yswdzic3MZ3Hagz97n5zdXiaMtm7ic36oTA/640?wx_fmt=png" data-type="png" data-w="342" src="https://mmbiz.qpic.cn/mmbiz_png/73icnXvmN7wOI0rvtgpcAvoymzwXc4GsnicX7nxUa21NoWg2J48JaZ95yswdzic3MZ3Hagz97n5zdXiaMtm7ic36oTA/640?wx_fmt=png"></section></section></section><section><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247644260&amp;idx=1&amp;sn=b54c9e45e37630f844b7548f1a46459b&amp;chksm=fbf840b1cc8fc9a73867c5e75e9e69acedcbb2ad91df9e8d3cdd2ae7a030ed9d401cb1d268e6&amp;scene=21#wechat_redirect" textvalue="你已选中了添加链接的内容" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="1"><span><span><img data-backh="49" data-backw="562" data-imgfileid="100224400" data-ratio="0.08796296296296297" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10vnQicwUlPf2ialpAYdmzYrlVpcicLWjT7Hib8ajEo8Bbz1t52iaM6zZkubQ/640?wx_fmt=jpeg" data-type="jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10vnQicwUlPf2ialpAYdmzYrlVpcicLWjT7Hib8ajEo8Bbz1t52iaM6zZkubQ/640?wx_fmt=jpeg"></span></span></a></section><section><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247644250&amp;idx=1&amp;sn=db6d18e36b3153a968d7a9c11d1a67a9&amp;chksm=fbf8408fcc8fc99952e603ba24d0a10256855a593aeaf9bd400d18e4c0f0f0a06e49fdd023f8&amp;scene=21#wechat_redirect" textvalue="你已选中了添加链接的内容" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="1"><span><span><img data-backh="49" data-backw="562" data-imgfileid="100224397" data-ratio="0.08796296296296297" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10gJJRKwUNkKhUqcj55lBzaMXv2Y2iaExAqFBf4CXibk9TP1LLzzgqZCuQ/640?wx_fmt=jpeg" data-type="jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10gJJRKwUNkKhUqcj55lBzaMXv2Y2iaExAqFBf4CXibk9TP1LLzzgqZCuQ/640?wx_fmt=jpeg"></span></span></a></section><section><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247642379&amp;idx=1&amp;sn=d7bff2587965494403b92ebbd921fab9&amp;chksm=fbf859decc8fd0c8e539552911861ca594baf3e53c2b84a43542eb904e70e52918ecf997f4e0&amp;scene=21#wechat_redirect" textvalue="你已选中了添加链接的内容" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="1"><span><span><img data-backh="49" data-backw="562" data-imgfileid="100224402" data-ratio="0.08796296296296297" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10iaZ62PXgrHr1RhZhPcddeFsKn5m2p5LElTzZTLnVnSK49vbJmm7cxPw/640?wx_fmt=jpeg" data-type="jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10iaZ62PXgrHr1RhZhPcddeFsKn5m2p5LElTzZTLnVnSK49vbJmm7cxPw/640?wx_fmt=jpeg"></span></span></a></section><section><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzU1MzMxMzcyMg==&amp;mid=2247644257&amp;idx=1&amp;sn=b3b7dceb825ef6b685e30d618a3b586e&amp;chksm=fbf840b4cc8fc9a2fddc9c5e1ac659f198df1ff30aa4f66f05d57d2bc775dc45a7a08aabecaf&amp;scene=21#wechat_redirect" textvalue="你已选中了添加链接的内容" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="1"><span><span><img data-backh="49" data-backw="562" data-imgfileid="100224403" data-ratio="0.08796296296296297" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10o3qRJVpkVYVkAvT13XS2DUTkibXVVWXuEcg0ic7gO2iaaYia11J5j2dKYg/640?wx_fmt=jpeg" data-type="jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJmPk4iag8IdicOQhSkCOEhI10o3qRJVpkVYVkAvT13XS2DUTkibXVVWXuEcg0ic7gO2iaaYia11J5j2dKYg/640?wx_fmt=jpeg"></span></span></a></section><section><span>设置<strong>星标</strong>，不错过精彩推文</span></section><section><img data-backh="119" data-backw="562" data-cropselx1="0" data-cropselx2="520" data-cropsely1="0" data-cropsely2="110" data-imgfileid="100224404" data-ratio="0.21203703703703702" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJkrZeMyHWr8nm80OyVfDQBpsT8rnQMxic0BEicTN0D4xTnoicumrbrBjUCh5uFtJEib7CLIeX8yxlUxcg/640?wx_fmt=jpeg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type="jpeg" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_jpg/HO0Z9pUcnJkrZeMyHWr8nm80OyVfDQBpsT8rnQMxic0BEicTN0D4xTnoicumrbrBjUCh5uFtJEib7CLIeX8yxlUxcg/640?wx_fmt=jpeg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></section><section><span><strong>开放转载</strong></span></section><section><span>欢迎转发到朋友圈和微信群</span></section><section powered-by="xiumi.us"><section><section><section data-id="1849" data-tools="新媒体排版" data-style-type="2"><section><section><span><strong><span> 微信加群 </span></strong><strong></strong></span></section><section><section><span><span>为促进前沿研究的传播和交流，我们组建了多个<strong>专业交流群</strong>，长按下方二维码，即可添加小编微信进群，由于申请人数较多，添加微信时请备注：<strong>学校</strong>/<strong>专业</strong>/<strong>姓名</strong>，如果是</span><span><strong>PI</strong></span><span>/</span><strong><span>教授</span></strong><span>，还请注明。</span></span></section><section><br></section><section><img data-cropselx1="0" data-cropselx2="163" data-cropsely1="0" data-cropsely2="163" data-fileid="100088553" data-imgfileid="100224405" data-ratio="1.3631578947368421" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/HO0Z9pUcnJlXd8xpTjuxrR42rUB5g9TNU1N6Qj1tyRwfGJIKKDn85DRJk7kfyLfYP5XsvVVPqa9sE8pcfaevbQ/640?wx_fmt=jpeg" data-type="jpeg" data-w="950" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/HO0Z9pUcnJlXd8xpTjuxrR42rUB5g9TNU1N6Qj1tyRwfGJIKKDn85DRJk7kfyLfYP5XsvVVPqa9sE8pcfaevbQ/640?wx_fmt=jpeg"></section></section></section></section></section></section></section><section><section><section><p><br></p><section><span><span><strong><strong><strong><strong>点</strong></strong></strong></strong></span><span><strong><strong><strong><strong>在看</strong></strong></strong></strong></span><span><strong><strong><strong><strong>，传递你的品味</strong></strong></strong></strong></span></span></section></section></section></section></section><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/GPSjKl0bCtwinHDH04ahRA",target="_blank" rel="noopener noreferrer">原文链接</a>
